People with multiple sclerosis (MS) often stop taking disease-modifying therapy as they transition from relapsing-remitting MS to secondary progressive MS. This study shows that people who stop stop ...
A chronic and progressive neurological condition that affects millions across the world, multiple sclerosis (MS) can be a ...
The results from a new study of the multi-kinase inhibitor fexagratinib in mouse models are raising hopes that the therapy ...
The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical and ...
Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers of multiple sclerosis progression.
A "groundbreaking" drug is being trialled in the first Brits to cure autoimmune conditions such as lupus and multiple ...
On Thursday night, Harrell’s Ennis team faced off against Corsicana High School in one of the most memorable games of a ...
Three patients in the UK have received a”groundbreaking” treatment for lupus on the NHS, which experts hope could eradicate ...
"Thus, progression is present in most, if not all, patients with multiple sclerosis, regardless of where they are ...
Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...
Hope Biosciences' stem cell therapy led to improved scores on a quality-of-life test for MS patients in a small clinical trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback